[DE] VERWENDUNG VON alpha 1L-AGONISTEN ZUR BEHANDLUNG DER HARNINKONTINENZ<br/>[EN] USE OF alpha 1L AGONISTS IN THE TREATMENT OF INCONTINENCE<br/>[FR] UTILISATION DE SUBSTANCES alpha 1L AGONISTES POUR LE TRAITEMENT DE L'INCONTINENCE
申请人:BOEHRINGER INGELHEIM KG
公开号:WO1996032939A1
公开(公告)日:1996-10-24
(DE) Die vorliegende Erfindung betrifft die Verwendung von $g(a)1L-Agonisten zur Behandlung der Harninkontinenz.(EN) The invention concerns the use of $g(a)1L agonists in the treatment of incontinence.(FR) L'invention concerne l'utilisation de substances $g(a)1L agonistes pour le traitement de l'incontinence.
Compounds and methods for treating urinary incontinence
申请人:Boehringer Ingelheim Pharma Gmbh & Co. KG
公开号:US20040198796A1
公开(公告)日:2004-10-07
Compounds of the formula (II)
1
wherein R
1
, R
2
, R
3
, R
4
, and R
5
are as set forth herein, pharmaceutical compositions containing them, and their use in treating urinary incontinence.